Author's Reply to Cryptogenic Stroke, Patent Foramen Ovale Closure, and Mid to Long-term Outcomes: Rising Shadows of Doubt

DOI QR Code

Oh-Hyun Lee (Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine and Cardiovascular Center, Yongin Severance Hospital) ;
Jung-Sun Kim (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine)

Dr. Jung-Sun Kim received a research grant from the Cardiovascular Research Center, Seoul, Korea.

Dell'Angela L, Nicolosi GL. Cryptogenic stroke, patent foramen ovale closure, and mid to long-term outcomes: rising shadows of doubt. Korean Circ J 2023;53:648-9.
Lee OH, Kim JS. Percutaneous patent foramen ovale closure after stroke. Korean Circ J 2022;52:801-7.
Kolokathis K, Thomopoulos C, Tsioufis K. Net clinical benefit of PFO closure versus medical treatment in patients with cryptogenic stroke: a systematic review and meta-analysis. Hellenic J Cardiol 2023;70:46-52.
Mojadidi MK, Elgendy AY, Elgendy IY, et al. Transcatheter patente foramen ovale closure after cryptogenic stroke: an updated meta-analysis of randomized trials. JACC Cardiovasc Interv 2017;10:2228-30.
Staubach S, Steinberg DH, Zimmermann W, et al. New onset atrial fibrillation after patent foramen ovale closure. Catheter Cardiovasc Interv 2009;74:889-95.
Skibsted CV, Korsholm K, Pedersen L, Bonnesen K, Nielsen-Kudsk JE, Schmidt M. Long-term risk of atrial fibrillation or flutter after transcatheter patent foramen ovale closure: a nationwide Danish study. Eur Heart J. 2023 [Epub ahead of print].
Trabattoni D, Gili S, Calligaris G, et al. Patent foramen ovale closure with the Occlutech Figulla flex II device: A long-term (up to 10-years) follow-up. Int J Cardiol. 2023 [Epub ahead of print].
Abrahamyan L, Barker M, Dharma C, et al. Real world long-term outcomes among adults undergoing transcatheter patent foramen closure with amplatzer PFO occluder. Int J Cardiol 2023;371:109-15.